Yuhan Corp Preferred - Asset Resilience Ratio
Yuhan Corp Preferred (000105) has an Asset Resilience Ratio of 0.99% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read how much debt does Yuhan Corp Preferred carry for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2014–2024)
This chart shows how Yuhan Corp Preferred's Asset Resilience Ratio has changed over time. See 000105 net asset value for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Yuhan Corp Preferred's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 000105 stock market capitalisation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 0% |
| Short-term Investments | ₩30.27 Billion | 0.99% |
| Total Liquid Assets | ₩30.27 Billion | 0.99% |
Asset Resilience Insights
- Limited Liquidity: Yuhan Corp Preferred maintains only 0.99% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Yuhan Corp Preferred Industry Peers by Asset Resilience Ratio
Compare Yuhan Corp Preferred's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Changchun High & New Technology Industries Group Inc
SHE:000661 |
Drug Manufacturers - Specialty & Generic | 3.73% |
|
Yuhan Corp.
KO:000100 |
Drug Manufacturers - Specialty & Generic | 0.99% |
|
Tasly Pharmaceutical Group Co Ltd
SHG:600535 |
Drug Manufacturers - Specialty & Generic | 9.09% |
|
Zhejiang Hisun Pharmaceutical Co Ltd
SHG:600267 |
Drug Manufacturers - Specialty & Generic | 0.02% |
|
Zhejiang Jiuzhou Pharm Co Ltd
SHG:603456 |
Drug Manufacturers - Specialty & Generic | 0.01% |
|
Shanghai Yizhong Pharmaceutical Co Ltd
SHG:688091 |
Drug Manufacturers - Specialty & Generic | 26.36% |
|
Jiangsu Kanion Pharmaceutical Co Ltd
SHG:600557 |
Drug Manufacturers - Specialty & Generic | 0.29% |
|
Cronos Group Inc
TO:CRON |
Drug Manufacturers - Specialty & Generic | 69.94% |
Annual Asset Resilience Ratio for Yuhan Corp Preferred (2014–2024)
The table below shows the annual Asset Resilience Ratio data for Yuhan Corp Preferred.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 0.82% | ₩24.23 Billion ≈ $16.42 Million |
₩2.94 Trillion ≈ $1.99 Billion |
+0.33pp |
| 2023-12-31 | 0.50% | ₩11.90 Billion ≈ $8.06 Million |
₩2.40 Trillion ≈ $1.63 Billion |
-1.72pp |
| 2022-12-31 | 2.21% | ₩54.68 Billion ≈ $37.06 Million |
₩2.47 Trillion ≈ $1.68 Billion |
-5.22pp |
| 2021-12-31 | 7.44% | ₩183.22 Billion ≈ $124.16 Million |
₩2.46 Trillion ≈ $1.67 Billion |
+3.59pp |
| 2020-12-31 | 3.85% | ₩92.11 Billion ≈ $62.42 Million |
₩2.39 Trillion ≈ $1.62 Billion |
-2.81pp |
| 2019-12-31 | 6.66% | ₩140.94 Billion ≈ $95.51 Million |
₩2.12 Trillion ≈ $1.43 Billion |
-4.10pp |
| 2018-12-31 | 10.76% | ₩233.84 Billion ≈ $158.47 Million |
₩2.17 Trillion ≈ $1.47 Billion |
-0.94pp |
| 2017-12-31 | 11.70% | ₩245.00 Billion ≈ $166.03 Million |
₩2.09 Trillion ≈ $1.42 Billion |
-0.11pp |
| 2016-12-31 | 11.81% | ₩241.58 Billion ≈ $163.71 Million |
₩2.05 Trillion ≈ $1.39 Billion |
+10.18pp |
| 2015-12-31 | 1.63% | ₩30.66 Billion ≈ $20.78 Million |
₩1.88 Trillion ≈ $1.27 Billion |
-3.19pp |
| 2014-12-31 | 4.82% | ₩77.93 Billion ≈ $52.81 Million |
₩1.62 Trillion ≈ $1.10 Billion |
-- |
About Yuhan Corp Preferred
Yuhan Corporation manufactures and sells prescription drugs, over-the-counter drugs, veterinary drugs, and household goods in South Korea and internationally. It also manufactures and sells animal feed and health functional food. The company was founded in 1926 and is headquartered in Seoul, South Korea.